VivoSeq
Other

Cholecystectomy

0

Pipeline Programs

2

Active Trials

0

Companies Involved

Cholecystectomy is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

91/100

Attrition Rate

6/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

16

clinical trials

Completed10 · 63%
Unknown status3 · 19%
Withdrawn1 · 6%
Recruiting1 · 6%
Not yet recruiting1 · 6%

Trial Activity

16 trials

EUS-GBD vs Antibiotics for Patients at High Risk for Cholecystectomy
Recruiting··Phase 3·NCT05893511·110 enrolled
Nonopioid Analgesics and Cholecystectomy
Completed··Phase 3·NCT04622813·90 enrolled
Pain Reduction After Cholecystectomy
Completed·MMeander Medical Center·Phase 4·NCT01199406·80 enrolled
Levobupivacaine During Cholecystectomy
Completed··Phase 4·NCT00836316·40 enrolled
Multimodal and Unimodal Analgesia in Cholecystectomy
Completed·OOctober 6 University·Phase 1/2·NCT05547659·95 enrolled
Prophylactic Antibiotic in Non-complicated Low Risk Lap Cholecystectomy (LC)
Unknown status··N/A·NCT06193837·200 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)